Bio-Techne (TECH) Other Operating Expenses (2009 - 2014)
Bio-Techne (TECH) posted quarterly Other Operating Expenses of -$2.4 million for Q3 2014, down 345.49% year-over-year from $965421.1 in Q3 2013, and down 345.49% quarter-over-quarter from -$532000.0 in Q3 2013.
Powered by 
Analysis
Bio-Techne (TECH) Other Operating Expenses (2009 - 2014) Analysis & Trends
Bio-Techne's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$2.4 million for Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | -2.37 Mn |
| Sep 30, 2013 | -532,000.00 |
| Jun 30, 2010 | -720,000.00 |
| Mar 31, 2010 | 240,000.00 |
| Dec 31, 2009 | 240,000.00 |
| Sep 30, 2009 | 240,000.00 |